Literature DB >> 14722888

Influence of promoter variants of interleukin-10, interleukin-9, and tumor necrosis factor-alpha genes on respiratory syncytial virus bronchiolitis.

Barbara Hoebee1, Louis Bont, Edwin Rietveld, Marijke van Oosten, Hennie M Hodemaekers, Nico J D Nagelkerke, Herman J Neijens, Jan L L Kimpen, Tjeerd G Kimman.   

Abstract

Previously, we reported genetic associations between severe respiratory syncytial virus (RSV) bronchiolitis in infants and polymorphisms in the interleukin (IL)-4 and IL-4 receptor alpha (IL-4Ralpha) genes, providing evidence for involvement of T helper type 2 cytokines in the pathogenesis of RSV bronchiolitis. We expanded our studies to polymorphisms in genes encoding IL-9, IL-10, and tumor necrosis factor (TNF)-alpha, using both a transmission/disequilibrium test and a case-control approach. Children homozygous for the IL-10 -592C or -592A allele had a higher risk of hospitalization for RSV bronchiolitis than did heterozygous carriers (odds ratio [OR], 1.73 vs. 2.55; 95% confidence interval [CI], 1.13-2.66 vs. 1.21-5.39). In children hospitalized at < or =6 months of age, a significant association between RSV bronchiolitis and the IL-10 -592C allele was found (OR, 1.61; 95% CI, 1.10-2.35). No significant associations of TNF-alpha and IL-9 polymorphisms with RSV bronchiolitis were observed. We also explored the interactions between different polymorphisms and found an interaction between the IL-4Ralpha Q551R and IL-10 C-592A polymorphisms.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14722888     DOI: 10.1086/380908

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  34 in total

1.  Respiratory syncytial virus load, viral dynamics, and disease severity in previously healthy naturally infected children.

Authors:  Chadi M El Saleeby; Andy J Bush; Lisa M Harrison; Jody A Aitken; John P Devincenzo
Journal:  J Infect Dis       Date:  2011-10-01       Impact factor: 5.226

2.  Novel inflammatory markers, clinical risk factors and virus type associated with severe respiratory syncytial virus infection.

Authors:  Christy M Tabarani; Cynthia A Bonville; Manika Suryadevara; Patrick Branigan; Dongliang Wang; Danning Huang; Helene F Rosenberg; Joseph B Domachowske
Journal:  Pediatr Infect Dis J       Date:  2013-12       Impact factor: 2.129

3.  Gene expression differences in lungs of mice during secondary immune responses to respiratory syncytial virus infection.

Authors:  Annemieke Schuurhof; Louis Bont; Jeroen L A Pennings; Hennie M Hodemaekers; Piet W Wester; Annemarie Buisman; Lia C G H de Rond; Myra N Widjojoatmodjo; Willem Luytjes; Jan L L Kimpen; Riny Janssen
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

4.  Host transcription profiles upon primary respiratory syncytial virus infection.

Authors:  Riny Janssen; Jeroen Pennings; Hennie Hodemaekers; Annemarie Buisman; Marijke van Oosten; Lia de Rond; Kemal Oztürk; Jan Dormans; Tjeerd Kimman; Barbara Hoebee
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

Review 5.  Evidence for a causal relationship between respiratory syncytial virus infection and asthma.

Authors:  Pingsheng Wu; Tina V Hartert
Journal:  Expert Rev Anti Infect Ther       Date:  2011-09       Impact factor: 5.091

Review 6.  Human genetic factors and respiratory syncytial virus disease severity.

Authors:  Isao Miyairi; John P DeVincenzo
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

7.  Severe respiratory syncytial virus infections and reduced interferon-gamma generation in vitro.

Authors:  U Schauer; S Hoffjan; T Rothoeft; H Bartz; S Konig; E Fuchs; J Bittscheidt; A Kochling; V Stephan
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

8.  Attenuated P2X7 pore function as a risk factor for virus-induced loss of asthma control.

Authors:  Loren C Denlinger; Lei Shi; Arturo Guadarrama; Kathy Schell; Dawn Green; Alison Morrin; Kirk Hogan; Ronald L Sorkness; William W Busse; James E Gern
Journal:  Am J Respir Crit Care Med       Date:  2008-11-21       Impact factor: 21.405

Review 9.  Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology.

Authors:  John S Tregoning; Jürgen Schwarze
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

10.  Systemic T-helper and T-regulatory cell type cytokine responses in rhinovirus vs. respiratory syncytial virus induced early wheezing: an observational study.

Authors:  Tuomas Jartti; Maria Paul-Anttila; Pasi Lehtinen; Vilhelmiina Parikka; Tytti Vuorinen; Olli Simell; Olli Ruuskanen
Journal:  Respir Res       Date:  2009-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.